1. Home
  2. PTLE vs QNRX Comparison

PTLE vs QNRX Comparison

Compare PTLE & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PTLE

PTL LTD Ordinary Shares

HOLD

Current Price

$0.11

Market Cap

10.1M

Sector

Energy

ML Signal

HOLD

Logo Quoin Pharmaceuticals Ltd.

QNRX

Quoin Pharmaceuticals Ltd.

HOLD

Current Price

$7.45

Market Cap

10.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTLE
QNRX
Founded
2013
2018
Country
Singapore
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.1M
10.1M
IPO Year
2024
N/A

Fundamental Metrics

Financial Performance
Metric
PTLE
QNRX
Price
$0.11
$7.45
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
9.6M
34.7K
Earning Date
11-03-2025
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$91,415,732.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.10
$5.01
52 Week High
$2.08
$41.80

Technical Indicators

Market Signals
Indicator
PTLE
QNRX
Relative Strength Index (RSI) 43.07 33.58
Support Level $0.11 $7.07
Resistance Level $0.12 $8.46
Average True Range (ATR) 0.01 0.88
MACD 0.00 -0.13
Stochastic Oscillator 8.44 19.75

Price Performance

Historical Comparison
PTLE
QNRX

About PTLE PTL LTD Ordinary Shares

PTL Ltd is a holding company. Through its subsidiaries, it is an established bunkering facilitator providing marine fuel logistics services for vessel refuelling, serving the Asia Pacific market. The company's services mainly involve facilitating with its suppliers to supply fuel for the use by the customers' vessels at various ports along their voyages in the Asia Pacific region; arranging vessel refuelling activities at competitive pricing to the customers; offering trade credit to the customers for vessel refuelling; handling unforeseeable circumstances faced by the customers and providing contingency solutions to the customers on time; and handling disputes, mainly concerning quality and quantity issues on marine fuel. The company derives its maximum revenue from Hong Kong.

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Share on Social Networks: